NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

NOVO.B.DK

256.05

-1.39%↓

GMAB.DK

1,786

-1.19%↓

HLUNB.DK

42.8

+0.94%↑

ZEAL.DK

318.9

-2.54%↓

AMBUB.DK

70.1

-0.78%↓

Search

Coloplast A-S (Class B)

Ouvert

437.5 -2.02

Résumé

Variation du prix de l'action

24h

Actuel

Min

435.8

Max

446.5

Chiffres clés

By Trading Economics

Revenu

522M

1.4B

Ventes

83M

7B

P/E

Moyenne du Secteur

24.148

63.808

BPA

6.32

Rendement du dividende

5.41

Marge bénéficiaire

19.835

Employés

16,983

EBITDA

309M

2.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.41%

2.38%

Prochains Résultats

12 mai 2026

Date du Prochain Dividende

20 mai 2026

Date du Prochain Détachement de Dividende

18 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-22B

96B

Ouverture précédente

439.52

Clôture précédente

437.5

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

19 avr. 2026, 23:48 UTC

Principaux Événements d'Actualité

Crude Oil, Refined Product Prices Moving Higher Amid Renewed Tensions in Strait of Hormuz -- OPIS

19 avr. 2026, 23:36 UTC

Principaux Événements d'Actualité

NAB Raises Provisions as Australian Banks Face Iran Risks -- Update

19 avr. 2026, 22:47 UTC

Principaux Événements d'Actualité

National Australia Bank Adds $215 Million in Iran-Driven Credit Provisions

19 avr. 2026, 21:14 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

19 avr. 2026, 21:14 UTC

Principaux Événements d'Actualité

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

19 avr. 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Gold, Silver Decline Amid Renewed Inflation Concerns -- Market Talk

19 avr. 2026, 23:46 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

19 avr. 2026, 23:38 UTC

Principaux Événements d'Actualité

U.A.E. Asks U.S. About a Wartime Financial Lifeline -- Update

19 avr. 2026, 23:36 UTC

Market Talk
Principaux Événements d'Actualité

Oil Climbs on Renewed Tensions Over Strait of Hormuz -- Market Talk

19 avr. 2026, 23:12 UTC

Principaux Événements d'Actualité

Spot Gold Falls 1.2%, Spot Silver Drops 1.6% on Renewed Middle East Tensions

19 avr. 2026, 23:10 UTC

Principaux Événements d'Actualité

Front-Month Brent Crude Oil Futures Rise 5.8% to $95.64 per Barrel

19 avr. 2026, 23:09 UTC

Principaux Événements d'Actualité

Front-Month WTI Crude Oil Futures Climb 7.2% to $89.86 per Barrel

19 avr. 2026, 23:08 UTC

Principaux Événements d'Actualité

Front-Month Crude Oil Futures Climb on Renewed Tensions Over Strait of Hormuz

19 avr. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Eli Lilly Nears Deal for Cancer Biotech -- WSJ

19 avr. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Announcement Could Come As Soon As Monday, Sources Say -- WSJ

19 avr. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Deal Expected to Be Worth Over $2B Plus Additional Milestones, Sources Say -- WSJ

19 avr. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Eli Lilly Nears Deal for Kelonia Therapeutics, Sources Say -- WSJ

19 avr. 2026, 20:03 UTC

Principaux Événements d'Actualité

U.A.E. Central Bank Governor Khaled Mohamed Balama Raised Swap Idea With Treasury Secretary Scott Bessent in Washington -- WSJ

19 avr. 2026, 20:03 UTC

Principaux Événements d'Actualité

Emiratis Portrayed Swap Proposal as Precautionary and Preliminary in Case Iran War Drags On -- WSJ

19 avr. 2026, 20:03 UTC

Principaux Événements d'Actualité

The U.A.E. Has Opened Talks with U.S. for Currency Swap -- WSJ

19 avr. 2026, 20:03 UTC

Principaux Événements d'Actualité

U.A.E. Asks U.S. for a Wartime Financial Lifeline -- WSJ

18 avr. 2026, 01:00 UTC

Principaux Événements d'Actualité

As Economic Pressures Mount, Will Iran or the U.S. Blink First? -- WSJ

17 avr. 2026, 22:58 UTC

Résultats

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17 avr. 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17 avr. 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 avr. 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17 avr. 2026, 20:52 UTC

Résultats

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17 avr. 2026, 20:50 UTC

Market Talk
Résultats
Acquisitions, Fusions, Rachats

Tech, Media & Telecom Roundup: Market Talk

17 avr. 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 avr. 2026, 20:29 UTC

Résultats

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat